Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Diagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care Assay.

Sörensen NA, Neumann JT, Ojeda F, Giannitsis E, Spanuth E, Blankenberg S, Westermann D, Zeller T.

Clin Chem. 2019 Nov 7. pii: clinchem.2019.307405. doi: 10.1373/clinchem.2019.307405. [Epub ahead of print]

PMID:
31699700
2.

Presepsin (sCD14-ST) Is a Novel Marker for Risk Stratification in Cardiac Surgery Patients.

Bomberg H, Klingele M, Wagenpfeil S, Spanuth E, Volk T, Sessler DI, Schäfers HJ, Groesdonk HV.

Anesthesiology. 2017 Apr;126(4):631-642. doi: 10.1097/ALN.0000000000001522.

PMID:
28099244
3.

Elevated plasma heparin-binding protein is associated with early death after resuscitation from cardiac arrest.

Ristagno G, Masson S, Tiainen M, Bendel S, Bernasconi R, Varpula T, Milani V, Vaahersalo J, Magnoli M, Spanuth E, Barlera S, Latini R, Hoppu S, Pettilä V, Skrifvars MB; FINNRESUSCI Study Group.

Crit Care. 2016 Aug 7;20(1):251. doi: 10.1186/s13054-016-1412-4.

4.

Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department.

Carpio R, Zapata J, Spanuth E, Hess G.

Clin Chim Acta. 2015 Oct 23;450:169-75. doi: 10.1016/j.cca.2015.08.013. Epub 2015 Aug 19.

PMID:
26296897
5.
6.

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.

Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgrò S, Fanizza C, Romero M, Tognoni G, Latini R, Gattinoni L; ALBIOS Study Investigators.

Crit Care. 2014 Jan 7;18(1):R6. doi: 10.1186/cc13183.

7.

High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Giannitsis E, Spanuth E, Horsch A, Kleber ME, Koch W, Grammer TB, Koenig W, März W.

Clin Chem Lab Med. 2013 Oct;51(10):2019-28. doi: 10.1515/cclm-2012-0786.

PMID:
24072576
8.

N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial.

Luchner A, Möckel M, Spanuth E, Möcks J, Peetz D, Baum H, Spes C, Wrede CE, Vollert J, Müller R, Katus H, Giannitsis E.

Eur J Heart Fail. 2012 Mar;14(3):259-67. doi: 10.1093/eurjhf/hfr171. Epub 2012 Jan 20.

9.

High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.

Ivandic BT, Spanuth E, Kleber M, Grammer TB, März W.

Clin Chem Lab Med. 2011 Jun;49(6):1053-8. doi: 10.1515/CCLM.2011.176. Epub 2011 May 17.

PMID:
21574877
10.

N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events from antiinflammatory drugs: a pilot trial.

Brune K, Katus HA, Moecks J, Spanuth E, Jaffe AS, Giannitsis E.

Clin Chem. 2008 Jul;54(7):1149-57. doi: 10.1373/clinchem.2007.097428. Epub 2008 May 1.

11.

N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis?

Häupl T, Burmester GR, Giannitsis E, Rohrlach T, Spanuth E, Parsch H, Brune K.

Ann Rheum Dis. 2007 Jun;66(6):838-9. No abstract available.

12.

Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation.

Ivandic BT, Spanuth E, Haase D, Lestin HG, Katus HA.

Clin Chem. 2007 Jul;53(7):1231-4. Epub 2007 May 10.

13.

Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study).

Schmidt-Gayk H, Spanuth E, Kötting J, Bartl R, Felsenberg D, Pfeilschifter J, Raue F, Roth HJ.

Clin Chem Lab Med. 2004 Jan;42(1):90-5.

PMID:
15061387
14.

Quantitative bedside testing of troponin T: is it equal to laboratory testing? The Cardiac Reader Troponin T (CARE T) study.

Goldmann BU, Langenbrink L, Matschuck G, Heeschen C, Kolbe-Busch S, Niederau C, Katz N, Wenserit C, Lestin HG, Brinker K, Kuhrt E, Tebbe U, Spanuth E, Hamm CW.

Clin Lab. 2004;50(1-2):1-10.

PMID:
15000216
15.
16.

[The role of antiphospholipid antibodies in patients with pre-eclampsia].

Schneider DM, Heilmann L, von Tempelhoff GF, Berg C, Spanuth E.

Zentralbl Gynakol. 1999;121(12):623-6. Review. German. No abstract available.

PMID:
10666875
17.

The effect of different exercise intensities on the fibrinolytic system.

Molz AB, Heyduck B, Lill H, Spanuth E, Röcker L.

Eur J Appl Physiol Occup Physiol. 1993;67(4):298-304.

PMID:
8299595
18.
19.

[Hemostasis and pre-eclampsia].

Heilmann L, Hojnacki B, Spanuth E.

Geburtshilfe Frauenheilkd. 1991 Mar;51(3):223-7. German.

PMID:
2055397
20.

Predictive value of fibrin monomers in postoperative deep vein thrombosis.

Vogel G, Spanuth E.

Klin Wochenschr. 1990 Oct 17;68(20):1020-6.

PMID:
2283791
21.

Experiences with a statistical quality control system (QCS) for coagulation diagnostics parameters.

Spanuth E, Breyer J.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(4):539-45.

PMID:
2465969
22.

Detection of soluble fibrin monomer complexes. Comparison of a haemagglutination assay with the ethanol gelation test.

Oehler G, Klaus H, Stötzer KE, Spanuth E.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(3):278-83.

PMID:
2465216

Supplemental Content

Loading ...
Support Center